Advertisement
Screener

REPLIGEN CORP (RGEN) Pre-Tax Margin

REPLIGEN CORP (RGEN) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin 6.93%.
  • 2026-03-31: Pre-Tax Margin 0.91%.
  • 2025-12-31: Pre-Tax Margin 9.66%.
  • 2025-09-30: Pre-Tax Margin 9.06%.

Complete source-backed pre-tax margin history.

Available history
2010-03-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-306.93%
2026-03-310.91%
2025-12-319.66%
2025-09-309.06%
2025-06-309.99%
2025-03-314.70%
2024-12-31-23.04%
2024-09-30-0.74%
2024-06-305.68%
2024-03-312.41%
2023-12-311.12%
2023-09-308.06%
2023-06-3015.81%
2023-03-3119.76%
2022-12-3128.37%
2022-09-3023.65%
2022-06-3028.78%
2022-03-3128.55%
2021-12-3118.68%
2021-09-3023.14%
2021-06-3027.22%
2021-03-3123.18%
2020-12-3113.60%
2020-09-3018.86%
2020-06-3018.32%
2020-03-3114.03%
2019-12-316.25%
2019-09-302.41%
2019-06-3013.61%
2019-03-3117.34%
2018-12-3113.23%
2018-09-3013.37%
2018-06-307.05%
2018-03-3110.21%
2017-12-313.72%
2017-09-30-5.53%
2017-06-3011.26%
2017-03-3113.30%
2016-12-316.12%
2016-09-308.97%
2016-06-3018.42%
2016-03-3110.12%
2015-12-315.57%
2015-09-3018.57%
2015-06-3020.28%
2015-03-3120.17%
2014-12-311.48%
2014-09-3014.75%
2014-06-3020.86%
2014-03-3133.06%
2013-12-3133.91%
2013-09-3043.26%
2013-06-3034.46%
2013-03-3122.01%
2012-12-3134.11%
2012-09-3011.85%
2012-06-3011.45%
2012-03-3110.02%
2011-09-307.01%
2011-06-30-0.73%
2011-03-31-34.38%
2010-09-308.53%
2010-06-3014.10%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-318.45%
2024-12-31-4.26%
2023-12-318.97%
2022-12-3127.34%
2021-12-3122.90%
2020-12-3116.17%
2019-12-319.68%
2018-12-3111.05%
2017-12-315.13%
2016-12-3111.18%
2015-12-3116.07%
2014-12-3117.53%
2013-12-3133.76%
2012-12-3118.10%
2011-03-31-0.16%
2010-03-31-23.36%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Immunovant, Inc. (IMVT)United States$7.028B-14.78